Day: February 26, 2021

COPENHAGEN, Denmark, Feb. 26, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced the launch of Outgrow GHD, a new online educational resource designed to help caregivers of children with growth hormone deficiency (GHD) in the United States (U.S.) navigate their personal GHD journeys.“We are excited to announce Outgrow GHD to support children with GHD and their families as they manage their lives with this rare endocrine disease. The resource is a place where caregivers of children with this rare disease can learn from and inspire each other,” said Ami Knoefler, Senior Director, Patient Advocacy and Product Communications at Ascendis Pharma. “Outgrow GHD reflects our commitment to improve awareness...

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Feb. 26, 2021 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming virtual investor and scientific conferences:Cowen 41stAnnual Health Care Conference, March 1 – 4, 2021Members of uniQure’s management team including Matt Kapusta, chief executive officer, and Ricardo Dolmetsch, Ph.D., president of research & development, will participate in virtual one-on-one investor meetings throughout the day on Monday, March 1.David Cooper, M.D., vice president of clinical research CNS, will participate on a panel discussion entitled “Developing and Commercializing Neurological Therapies” on Thursday, March 4 at 1:30 p.m. ET....

Vincit OyjYhtiötiedote 26.2.2021 kello 14:00Vincit Oyj:n toimintakertomus ja tilinpäätös vuodelta 2020 julkaistuVincit Oyj on julkaissut hallituksen toimintakertomuksen ja tilinpäätöksen vuodelta 2020.Hallituksen toimintakertomus ja tilinpäätös 2020 on saatavilla PDF-muotoisena tämän tiedotteen liitteenä sekä yhtiön verkkosivuilta osoitteessa http://www.vincit.fi/fi/sijoittajille/raportit-ja-esitykset/.Lisätietoja:Vincit Oyj, toimitusjohtaja Mikko Kuitunen, puhelin: 040 589 8316Hyväksytty neuvonantaja: Alexander Corporate Finance Oy, puhelin: 050 520 4098Vincit Oyj lyhyesti:Vincit on huippuasiantuntijaorganisaatio, joka tarjoaa asiakkailleen aina toimivinta digitaalisuutta ymmärrettävässä paketissa, jotta huominen ei pelota. Vincit Oyj:n osakkeet on listattu Nasdaq Helsinki Oy:n ylläpitämällä Nasdaq First North Growth Market Finland -markkinapaikalla,...

YTD Q4 2020, the Jotul Group reached a consolidated profit of MNOK -128.9 (Q4 2019: MNOK -86.8). The operating result totaled MNOK -66.7 in YTD Q4 2020 (Q4 2019: MNOK 27.3). The 2020 total comprehensive loss for YTD Q4 was MNOK -127.5 (Q4 2019: MNOK     – 85.7).Sales for the period declined by 6.1% to MNOK 905.5 YTD Q4 2020 (Q4 2019 MNOK 961,1), which is less than initially anticipated at the outbreak of the COVID-19 pandemic. The fourth quarter continued to show a strong recovery in order intake, up from MNOK 269 in Q4 2019 to MNOK 305 in Q4 2020. Total order book as per Q4 2020 was MNOK 122 (Q4 2019 MNOK 29). In addition to the strong recovery in the market during the second half of 2020, the large backlog as per Q4 2020 is also related to the limited output capacity at the new production facility in Poland during the pandemic.In...

Silence Therapeutics and Mallinckrodt Initiate Work on Third Target as Part of Ongoing RNAi Research Collaboration for Complement-Mediated DiseasesSilence to receive $2 million research milestone paymentSilence is also eligible to receive up to $2 billion in total milestone payments across all three targets and tiered double-digit royalties on net sales for each product candidate26 February 2021LONDON, Silence Therapeutics plc, AIM:SLN and Nasdaq: SLN (“Silence” or “the Company”), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the treatment of diseases with significant unmet medical need, today announced the Company will receive a $2.0 million milestone payment following the initiation of work on a third target being explored under its ongoing RNAi research collaboration...

New York, NY, Feb. 26, 2021 (GLOBE NEWSWIRE) — George Goldsmith, Chairman & CEO, to participate in Neuropsych Panel discussion London, UK – 26 February 2021-Ends-About COMPASS PathwaysCOMPASS Pathways plc (Nasdaq: CMPS) is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. We are pioneering the development of a new model of psilocybin therapy, in which our proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support. COMP360 has been designated a Breakthrough Therapy by the US Food and Drug Administration (FDA), for treatment-resistant depression (TRD), and we are currently...

CAMBRIDGE, Mass., Feb. 26, 2021 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that its fourth quarter and full year 2020 financial results will be released on Thursday, March 4, 2021 before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments.Dial-in NumberU.S./Canada Dial-in Number: 800-527-6973International Dial-in Number: 470-495-9162Conference ID: 6376419Replay Dial-in Number: 855-859-2056Replay International Dial-in Number: 404-537-3406Conference ID: 6376419An audio webcast will be accessible through the Investor Relations section of the company’s...

All amounts in U.S. dollars unless otherwise statedTORONTO, Feb. 26, 2021 (GLOBE NEWSWIRE) — Onex Corporation (TSX: ONEX) today announced its financial results for the fourth quarter and full year ended December 31, 2020.“We delivered strong results in the fourth quarter and full year 2020. Our disciplined approach to investing was tested and, once again, proved resilient against a challenging economic backdrop,” said Gerry Schwartz, Chairman and Chief Executive Officer of Onex. “I am immensely proud of the work our team did over the year. Everyone demonstrated the flexibility and entrepreneurial spirit that is core to our culture. We continued to build upon our strong foundation and our platforms had good momentum, which positions us well for continued growth in the years to come.”HighlightsOnex reported segment net earnings for...

CAMBRIDGE, Mass., Feb. 26, 2021 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced the company’s recognition of Rare Disease Day 2021.“While COVID-19 has had an impact on most people around the world, it has put a new spotlight on the importance of connectivity and community for people affected by rare diseases who are at a higher risk of feelings of isolation and can face significant challenges in accessing information and healthcare services,” said Robert J. Gould, Ph.D., Fulcrum’s president and chief executive officer. “We have been privileged to work with many patients and caregivers affected by genetically defined diseases including facioscapulohumeral muscular dystrophy and...

WINNIPEG, Manitoba, Feb. 26, 2021 (GLOBE NEWSWIRE) — DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”), is pleased to announce it has introduced new services to meet consumer demand for online ordering in all retail markets it serves. Delta 9 already has a robust online service in the Manitoba market and it has now launched a province wide delivery service in Saskatchewan and same-day home delivery service program to the Lloydminster, Saskatchewan marketplace. Delta 9 has also launched an online order service allowing customers to reserve products from Delta 9 stores in Calgary and Grande Prairie and have them ready for pick up within one hour.“Delta 9 has a distinct competitive advantage as online ordering and same day delivery services become more available at Delta 9 stores in...